JNJ backtesting the necklineJNJ had broken down from a h&S and almost hit the measured move target 128. now it is back testing the neckline again. let's see how it goes
DJNJ3 trade ideas
$JNJ Looks a certain short from here. $120 NEXT STOP*****INVESTORS IN NYSE:JNJ CAN'T WAIT FOR MAY TO BE OVER, ALREADY DOWN 7% AND 5% IN ONE DAY , NEXT SUPPORT IS ANOTHER 6% AWAY AND IT LOOKS VERY MUCH LIKE THAT IS WHERE THE PRICE IS GOING. OPIOID LITIGATIONS CONTINUE TO BE A DRAG ON SENTIMENT AND THAT ISSUE WILL INTENSIFY AS THE CRISIS INTENSIFIES.
AVERAGE ANALYSTS RETAIL PRICE $148
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 24
Shorting JNJ sharesOn the daily chart, the instrument has started a new bearish trend as the price is moving under the Alligator indicator with AO below the zero line after divergence in the correction. I expect the price to continue the downfall if we break the recently formed sell fractal. My TP and SL levels are marked on the chart.
JNJ through 141Tight entry on JNJ for a potential $5 move
If I see it flag under $146, I’ll buy through there as well
Johnson & Johnson head and shouldersLooks like a right shoulder could be forming, weekly chart offers a nice view and divergence for the H&S pattern. A break to the low through 200SMA on a daily chart could signal a nice short. J&J tasked a Federal Judge to take over the 2400 lawsuits because of the baby powder fiasco so company is still dealing with the fallout.
Could be a good trade for next week. Although earnings on Tuesday were positive there was no bullish spike.
Have a great Easter weekend!
JNJ: Stuck in a trading range, buybacks are supporting the stockA weekly chart reveals the long-term trading range in which JNJ has been stuck. This Dow component ran up due to buybacks around the start of this year. But the trend and volume-based indicators show a lack of quiet accumulation by Dark Pools. The stock slid down ahead of its earnings release today and gapped up slightly on the report, but there has been considerable profit-taking today as well. So JNJ remains bound in a narrower range just below the trading range highs, where it could languish for some time.
JNJ LOngBouncing off the channel and trying to defend the 100 ema #technicalanalysis #chartpatterns #Gann #JNJ
Double inside candleTwo inside candles have formed after the big red candle of 3 days ago.
Generally inside candles indicate a pause in the current trend and as these two happen to also be dojis they caught my attention. Price action is currently near most recent support which might indicate a swing is around the corner.
Johnson & Johnson opportunityRising channel now testing its low and 200SMA. Potential to buy with a good risk-reward. Or see if we break lower on the open of the US session.
$JNJ developing bearflag$JNJ is possibility developing a bear flag. the low will be tested if it brokedown
JNJ - Weekly Review Feb 25 - Mar 01Weekly Outlook chart is in the related ideas. JNJ ran up on the first day of the week. Couldn't hit daily profit target and sold off after hitting the upper trend line of the channel, pulled back the next couple of days and then made a move up and hit both daily and weekly profit targets before selling off and then finally on Friday it broke and closed above the targets finding resistance on the monthly resistance.
$JNJ - Weekly Outlook Feb 25 - Mar 01$JNJ is in a up trending channel and pushing against the upper trend line of the channel. I am seeing resistance area at 137.80 - 138.30. It bounced off daily support nicely and headed straight up. I feel confident it will hit the first profit target 137.80 early next week. This is where you should be taking profits if you are in JNJ. If JNJ runs next week, second profit target 139.55 is also possible.
I got into JNJ when I saw it successfully bounced off support and I will exit my position when it hits 137.80 which could be Monday or Tuesday (unless for any reason market sells off at the start of the week). For a longer-term JNJ perspective, Mar 04 looks to be the date when FDA is expected to give its approval on the JNJ's new depression drug. Once approved, JNJ can see a decent pump.
US-China trade news can make it go in either direction. Deadline of Mar 01 is next week. Next week is news critical. Markets will make moves depending on what kind of trade-related news we get.
If you would like me to analyse a stock ticker, please feel free to mention in the comments.
News article for JNJ's new depression drug: www.businessinsider.com
